A detailed history of Lummis Asset Management, LP transactions in Abbott Laboratories stock. As of the latest transaction made, Lummis Asset Management, LP holds 16,840 shares of ABT stock, worth $1.93 Million. This represents 2.24% of its overall portfolio holdings.

Number of Shares
16,840
Previous 14,025 20.07%
Holding current value
$1.93 Million
Previous $1.46 Billion 31.74%
% of portfolio
2.24%
Previous 1.92%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$100.07 - $118.13 $281,697 - $332,535
2,815 Added 20.07%
16,840 $1.92 Billion
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $27,297 - $30,471
271 Added 1.97%
14,025 $1.46 Billion
Q1 2024

May 16, 2024

SELL
$109.52 - $120.96 $1.63 Million - $1.8 Million
-14,863 Reduced 51.94%
13,754 $1.56 Billion
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $2.58 Million - $3.16 Million
28,617 New
28,617 $3.15 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lummis Asset Management, LP Portfolio

Follow Lummis Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lummis Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lummis Asset Management, LP with notifications on news.